> top > docs > PMC:2800179 > spans > 20326-21911 > annotations

PMC:2800179 / 20326-21911 JSONTXT

Annnotations TAB JSON ListView MergeView

GO-CC

Id Subject Object Predicate Lexical cue
T8659 61-65 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T8660 342-346 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T8661 415-420 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8662 484-489 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8663 534-539 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8664 581-586 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8665 652-657 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8666 800-805 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T8667 936-940 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T16604 1056-1060 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T16605 1435-1439 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

GO-BP

Id Subject Object Predicate Lexical cue
T8651 21-29 http://purl.obolibrary.org/obo/GO_0009056 denotes Degraded
T8652 43-65 http://purl.obolibrary.org/obo/GO_0008283 denotes Proliferation and Cell
T8653 61-71 http://purl.obolibrary.org/obo/GO_0007049 denotes Cell Cycle
T8654 330-340 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T8655 704-714 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T8656 427-435 http://purl.obolibrary.org/obo/GO_0051318 denotes G1 phase
T8657 550-558 http://purl.obolibrary.org/obo/GO_0051318 denotes G1 phase
T8658 816-823 http://purl.obolibrary.org/obo/GO_0000279 denotes M phase
T16592 1030-1038 http://purl.obolibrary.org/obo/GO_0009056 denotes Degraded
T16593 1056-1066 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T16594 1435-1445 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T16595 1056-1073 http://purl.obolibrary.org/obo/GO_0071156 denotes cell cycle arrest
T16596 1056-1073 http://purl.obolibrary.org/obo/GO_0071850 denotes cell cycle arrest
T16597 1056-1073 http://purl.obolibrary.org/obo/GO_0007050 denotes cell cycle arrest
T16598 1077-1085 http://purl.obolibrary.org/obo/GO_0051318 denotes G1 phase
T16599 1114-1120 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T16600 1422-1445 http://purl.obolibrary.org/obo/GO_0098763 denotes phase of the cell cycle
T16601 1422-1445 http://purl.obolibrary.org/obo/GO_0022403 denotes phase of the cell cycle
T16602 1422-1445 http://purl.obolibrary.org/obo/GO_0044770 denotes phase of the cell cycle
T16603 1422-1445 http://purl.obolibrary.org/obo/GO_0098762 denotes phase of the cell cycle

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T8232 0-6 NN denotes Effect
T8233 7-9 IN denotes of
T8234 10-16 JJ denotes Native
T8235 17-20 CC denotes and
T8236 21-29 VB denotes Degraded
T8237 30-33 NN denotes CGN
T8238 34-36 IN denotes on
T8239 37-42 NN denotes THP-1
T8240 43-56 NN denotes Proliferation
T8241 57-60 CC denotes and
T8242 61-65 NNP denotes Cell
T8243 66-71 NNP denotes Cycle
T8244 72-83 JJ denotes Preliminary
T8245 84-96 NN denotes observations
T8246 97-99 IN denotes by
T8247 100-111 NN denotes enumeration
T8248 112-114 IN denotes of
T8249 115-120 NN denotes THP-1
T8250 121-126 NN denotes cells
T8251 127-134 VB denotes exposed
T8252 135-137 TO denotes to
T8253 138-147 JJ denotes different
T8254 148-162 NN denotes concentrations
T8255 163-165 IN denotes of
T8256 166-172 JJ denotes native
T8257 173-176 CC denotes and
T8258 177-181 NN denotes dCGN
T8259 182-183 -LRB- denotes (
T8260 183-185 CD denotes 10
T8261 186-189 CC denotes and
T8262 190-192 CD denotes 40
T8263 193-196 NN denotes kDa
T8264 196-197 -RRB- denotes )
T8265 198-204 IN denotes during
T8266 205-206 CD denotes 2
T8267 206-207 -COMMA- denotes ,
T8268 208-209 CD denotes 5
T8269 210-213 CC denotes and
T8270 214-215 CD denotes 7
T8271 216-220 NN denotes days
T8272 220-221 -COMMA- denotes ,
T8273 222-228 VB denotes showed
T8274 229-230 DT denotes a
T8275 231-238 NN denotes decline
T8276 239-241 IN denotes in
T8277 242-246 NN denotes cell
T8278 247-253 NN denotes number
T8279 254-255 -LRB- denotes (
T8280 255-259 NN denotes data
T8281 260-263 RB denotes not
T8282 264-269 VB denotes shown
T8283 269-270 -RRB- denotes )
T8284 272-276 DT denotes This
T8285 277-286 VB denotes suggested
T8286 287-291 IN denotes that
T8287 292-296 NN denotes dCGN
T8288 297-302 MD denotes might
T8289 303-308 VB denotes cause
T8290 309-311 DT denotes an
T8291 312-322 NN denotes alteration
T8292 323-325 IN denotes in
T8293 326-329 DT denotes the
T8294 330-334 NN denotes cell
T8295 335-340 NN denotes cycle
T8296 342-346 NN denotes Cell
T8297 347-352 NN denotes cycle
T8298 353-361 NN denotes analysis
T8299 362-367 VB denotes using
T8300 368-372 NN denotes flow
T8301 373-382 NN denotes cytometry
T8302 383-389 VB denotes showed
T8303 390-392 DT denotes an
T8304 393-405 NN denotes accumulation
T8305 406-408 IN denotes of
T8306 409-414 NN denotes THP-1
T8307 415-420 NN denotes cells
T8308 421-423 IN denotes in
T8309 424-429 NN denotes G0/G1
T8310 430-435 NN denotes phase
T8311 435-436 -COMMA- denotes ,
T8312 437-442 WDT denotes which
T8313 443-446 VB denotes was
T8314 447-457 VB denotes associated
T8315 458-462 IN denotes with
T8316 463-464 DT denotes a
T8317 465-473 NN denotes decrease
T8318 474-480 NN denotes number
T8319 481-483 IN denotes of
T8320 484-489 NN denotes cells
T8321 490-492 IN denotes in
T8322 493-496 DT denotes the
T8323 497-498 NN denotes S
T8324 499-504 NN denotes phase
T8325 505-506 -LRB- denotes (
T8326 506-510 NN denotes Fig.
T8327 511-513 NN denotes 3A
T8328 513-514 -RRB- denotes )
T8329 516-519 DT denotes The
T8330 520-530 NN denotes percentage
T8331 531-533 IN denotes of
T8332 534-539 NN denotes cells
T8333 540-542 IN denotes in
T8334 543-546 DT denotes the
T8335 547-552 NN denotes G0/G1
T8336 553-558 NN denotes phase
T8337 559-562 VB denotes was
T8338 563-567 CD denotes 45.2
T8339 567-568 NN denotes %
T8340 569-572 IN denotes for
T8341 573-580 NN denotes control
T8342 581-586 NN denotes cells
T8343 586-587 -COMMA- denotes ,
T8344 588-592 CD denotes 62.6
T8345 592-593 NN denotes %
T8346 594-597 IN denotes for
T8347 598-601 NN denotes C10
T8348 602-606 NN denotes dCGN
T8349 607-608 -LRB- denotes (
T8350 608-610 IN denotes at
T8351 611-612 CD denotes 2
T8352 613-618 NN denotes mg/ml
T8353 618-619 -RRB- denotes )
T8354 619-620 -COMMA- denotes ,
T8355 621-624 CC denotes and
T8356 625-629 CD denotes 64.2
T8357 629-630 NN denotes %
T8358 631-634 IN denotes for
T8359 635-638 NN denotes C40
T8360 639-651 JJ denotes dCGN-treated
T8361 652-657 NN denotes cells
T8362 658-659 -LRB- denotes (
T8363 659-661 IN denotes at
T8364 662-663 CD denotes 2
T8365 664-669 NN denotes mg/ml
T8366 669-670 -RRB- denotes )
T8367 671-672 -LRB- denotes (
T8368 672-676 NN denotes Fig.
T8369 677-679 NN denotes 3B
T8370 679-680 -RRB- denotes )
T8371 682-685 DT denotes The
T8372 686-692 NN denotes effect
T8373 693-695 IN denotes of
T8374 696-700 NN denotes dCGN
T8375 701-703 IN denotes on
T8376 704-708 NN denotes cell
T8377 709-714 NN denotes cycle
T8378 715-718 VB denotes was
T8379 719-733 JJ denotes dose-dependent
T8380 734-735 -LRB- denotes (
T8381 735-739 NNP denotes Fig.
T8382 740-742 NN denotes 3B
T8383 742-743 -RRB- denotes )
T8384 745-752 CC denotes Neither
T8385 753-759 JJ denotes native
T8386 760-763 CC denotes nor
T8387 764-768 NN denotes dCGN
T8388 769-772 VB denotes had
T8389 773-775 DT denotes an
T8390 776-782 NN denotes effect
T8391 783-785 IN denotes on
T8392 786-789 DT denotes the
T8393 790-796 NN denotes number
T8394 797-799 IN denotes of
T8395 800-805 NN denotes cells
T8396 806-808 IN denotes in
T8397 809-812 DT denotes the
T8398 813-817 NN denotes G2/M
T8399 818-823 NN denotes phase
T8400 824-825 -LRB- denotes (
T8401 825-829 NN denotes Fig.
T8402 830-831 CD denotes 3
T8403 831-832 -RRB- denotes )
T8404 834-838 DT denotes This
T8405 839-845 NN denotes effect
T8406 846-848 VB denotes is
T8407 849-852 RB denotes not
T8408 853-856 JJ denotes due
T8409 857-859 TO denotes to
T8410 860-872 NN denotes cytotoxicity
T8411 873-875 IN denotes of
T8412 876-880 NN denotes dCGN
T8413 881-885 RB denotes even
T8414 886-888 IN denotes at
T8415 889-892 DT denotes the
T8416 893-900 JJ denotes highest
T8417 901-914 NN denotes concentration
T8418 915-916 -LRB- denotes (
T8419 916-920 FW denotes i.e.
T8420 921-922 CD denotes 2
T8421 923-928 NN denotes mg/ml
T8422 928-929 -RRB- denotes )
T8423 930-935 IN denotes since
T8424 936-940 NN denotes cell
T8425 941-950 NN denotes viability
T8426 951-954 VB denotes was
T8427 955-958 RB denotes not
T8428 959-967 VB denotes affected
T8429 968-969 -LRB- denotes (
T8430 969-973 NN denotes data
T8431 974-977 RB denotes not
T8432 978-983 VB denotes shown
T8433 983-984 -RRB- denotes )
T16354 1067-1073 NN denotes arrest
T16348 1030-1038 VB denotes Degraded
T16349 1039-1042 NN denotes CGN
T16350 1043-1050 VB denotes induced
T16351 1051-1055 NN denotes THP1
T16352 1056-1060 NN denotes cell
T16353 1061-1066 NN denotes cycle
T16355 1074-1076 IN denotes in
T16356 1077-1079 NN denotes G1
T16357 1080-1085 NN denotes phase
T16358 1087-1092 NN denotes THP-1
T16359 1093-1098 NN denotes cells
T16360 1099-1101 IN denotes in
T16361 1102-1113 JJ denotes exponential
T16362 1114-1120 NN denotes growth
T16363 1121-1126 NN denotes phase
T16364 1127-1131 VB denotes were
T16365 1132-1141 VB denotes incubated
T16366 1142-1144 IN denotes in
T16367 1145-1148 DT denotes the
T16368 1149-1157 NN denotes presence
T16369 1158-1160 CC denotes or
T16370 1161-1168 NN denotes absence
T16371 1169-1171 IN denotes of
T16372 1172-1183 NN denotes carrageenan
T16373 1184-1187 IN denotes for
T16374 1188-1190 CD denotes 24
T16375 1191-1192 NN denotes h
T16376 1193-1199 IN denotes before
T16377 1200-1205 VB denotes being
T16378 1206-1213 VB denotes stained
T16379 1214-1218 IN denotes with
T16380 1219-1228 NN denotes propidium
T16381 1229-1235 NN denotes iodide
T16382 1237-1241 NN denotes Cell
T16383 1242-1245 NN denotes DNA
T16384 1246-1253 NN denotes content
T16385 1254-1257 VB denotes was
T16386 1258-1262 RB denotes then
T16387 1263-1271 VB denotes analyzed
T16388 1272-1274 IN denotes by
T16389 1275-1279 NN denotes flow
T16390 1280-1289 NN denotes cytometry
T16391 1291-1292 DT denotes A
T16392 1292-1293 -COLON- denotes :
T16393 1294-1304 NN denotes Histograms
T16394 1305-1307 IN denotes of
T16395 1308-1313 NN denotes cells
T16396 1314-1321 VB denotes treated
T16397 1322-1326 IN denotes with
T16398 1327-1333 NN denotes medium
T16399 1334-1338 RB denotes only
T16400 1339-1340 -LRB- denotes (
T16401 1340-1347 NN denotes control
T16402 1347-1348 -RRB- denotes )
T16403 1348-1349 -COMMA- denotes ,
T16404 1350-1352 CD denotes 10
T16405 1353-1356 NN denotes kDa
T16406 1357-1361 NN denotes dCGN
T16407 1362-1363 -LRB- denotes (
T16408 1363-1366 NN denotes C10
T16409 1366-1367 -RRB- denotes )
T16410 1367-1368 -COMMA- denotes ,
T16411 1369-1371 CC denotes or
T16412 1372-1374 CD denotes 40
T16413 1375-1378 NN denotes kDa
T16414 1379-1383 NN denotes dCGN
T16415 1384-1385 -LRB- denotes (
T16416 1385-1388 NN denotes C40
T16417 1388-1389 -RRB- denotes )
T16418 1391-1392 NN denotes B
T16419 1392-1393 -COLON- denotes :
T16420 1394-1404 NN denotes Percentage
T16421 1405-1407 IN denotes of
T16422 1408-1413 NN denotes cells
T16423 1414-1416 IN denotes in
T16424 1417-1421 DT denotes each
T16425 1422-1427 NN denotes phase
T16426 1428-1430 IN denotes of
T16427 1431-1434 DT denotes the
T16428 1435-1439 NN denotes cell
T16429 1440-1445 NN denotes cycle
T16430 1446-1450 WRB denotes when
T16431 1451-1458 VB denotes treated
T16432 1459-1463 IN denotes with
T16433 1464-1470 NN denotes medium
T16434 1471-1475 RB denotes only
T16435 1476-1477 -LRB- denotes (
T16436 1477-1484 NN denotes control
T16437 1484-1485 -RRB- denotes )
T16438 1485-1486 -COMMA- denotes ,
T16439 1487-1496 JJ denotes different
T16440 1497-1511 NN denotes concentrations
T16441 1512-1514 IN denotes of
T16442 1515-1517 CD denotes 10
T16443 1518-1521 NN denotes kDa
T16444 1522-1526 NN denotes dCGN
T16445 1527-1528 -LRB- denotes (
T16446 1528-1531 NN denotes C10
T16447 1531-1532 -RRB- denotes )
T16448 1532-1533 -COMMA- denotes ,
T16449 1534-1536 IN denotes of
T16450 1537-1539 CD denotes 40
T16451 1540-1543 NN denotes kDa
T16452 1544-1548 NN denotes dCGN
T16453 1549-1550 -LRB- denotes (
T16454 1550-1553 NN denotes C40
T16455 1553-1554 -RRB- denotes )
T16456 1554-1555 -COMMA- denotes ,
T16457 1556-1558 CC denotes or
T16458 1559-1561 IN denotes of
T16459 1562-1568 JJ denotes native
T16460 1569-1572 NN denotes CGN
T16461 1573-1574 -LRB- denotes (
T16462 1574-1580 JJ denotes Native
T16463 1580-1581 -RRB- denotes )
R7238 T8232 T8233 arg1Of Effect,of
R7239 T8232 T8238 arg1Of Effect,on
R7240 T8234 T8235 arg1Of Native,and
R7241 T8236 T8235 arg2Of Degraded,and
R7242 T8237 T8233 arg2Of CGN,of
R7243 T8237 T8234 arg1Of CGN,Native
R7244 T8237 T8236 arg2Of CGN,Degraded
R7245 T8240 T8239 arg1Of Proliferation,THP-1
R7246 T8240 T8241 arg1Of Proliferation,and
R7247 T8241 T8238 arg2Of and,on
R7248 T8243 T8241 arg2Of Cycle,and
R7249 T8243 T8242 arg1Of Cycle,Cell
R7250 T8245 T8244 arg1Of observations,Preliminary
R7251 T8245 T8246 arg1Of observations,by
R7252 T8245 T8273 arg1Of observations,showed
R7253 T8247 T8246 arg2Of enumeration,by
R7254 T8247 T8248 arg1Of enumeration,of
R7255 T8247 T8251 arg2Of enumeration,exposed
R7256 T8250 T8248 arg2Of cells,of
R7257 T8250 T8249 arg1Of cells,THP-1
R7258 T8251 T8252 arg1Of exposed,to
R7259 T8254 T8252 arg2Of concentrations,to
R7260 T8254 T8253 arg1Of concentrations,different
R7261 T8254 T8255 arg1Of concentrations,of
R7262 T8258 T8255 arg2Of dCGN,of
R7263 T8258 T8256 arg1Of dCGN,native
R7264 T8258 T8257 arg1Of dCGN,and
R7265 T8258 T8259 arg1Of dCGN,(
R7266 T8258 T8265 arg1Of dCGN,during
R7267 T8260 T8261 arg1Of 10,and
R7268 T8262 T8261 arg2Of 40,and
R7269 T8263 T8259 arg2Of kDa,(
R7270 T8263 T8260 arg1Of kDa,10
R7271 T8263 T8262 arg1Of kDa,40
R7272 T8264 T8259 arg3Of ),(
R7273 T8266 T8267 arg1Of 2,","
R7274 T8267 T8269 arg1Of ",",and
R7275 T8268 T8267 arg2Of 5,","
R7276 T8270 T8269 arg2Of 7,and
R7277 T8271 T8265 arg2Of days,during
R7278 T8271 T8266 arg1Of days,2
R7279 T8271 T8268 arg1Of days,5
R7280 T8271 T8270 arg1Of days,7
R7281 T8273 T8272 arg1Of showed,","
R7282 T8275 T8273 arg2Of decline,showed
R7283 T8275 T8274 arg1Of decline,a
R7284 T8275 T8276 arg1Of decline,in
R7285 T8278 T8276 arg2Of number,in
R7286 T8278 T8277 arg1Of number,cell
R7287 T8278 T8279 arg1Of number,(
R7288 T8280 T8279 arg2Of data,(
R7289 T8280 T8282 arg2Of data,shown
R7290 T8282 T8281 arg1Of shown,not
R7291 T8283 T8279 arg3Of ),(
R7292 T8284 T8285 arg1Of This,suggested
R7293 T8287 T8288 arg1Of dCGN,might
R7294 T8287 T8289 arg1Of dCGN,cause
R7295 T8289 T8285 arg2Of cause,suggested
R7296 T8289 T8286 arg1Of cause,that
R7297 T8289 T8288 arg2Of cause,might
R7298 T8291 T8289 arg2Of alteration,cause
R7299 T8291 T8290 arg1Of alteration,an
R7300 T8291 T8292 arg1Of alteration,in
R7301 T8295 T8292 arg2Of cycle,in
R7302 T8295 T8293 arg1Of cycle,the
R7303 T8295 T8294 arg1Of cycle,cell
R7304 T8298 T8296 arg1Of analysis,Cell
R7305 T8298 T8297 arg1Of analysis,cycle
R7306 T8298 T8299 arg1Of analysis,using
R7307 T8298 T8302 arg1Of analysis,showed
R7308 T8301 T8299 arg2Of cytometry,using
R7309 T8301 T8300 arg1Of cytometry,flow
R7310 T8304 T8302 arg2Of accumulation,showed
R7311 T8304 T8303 arg1Of accumulation,an
R7312 T8304 T8305 arg1Of accumulation,of
R7313 T8304 T8308 arg1Of accumulation,in
R7314 T8304 T8311 arg1Of accumulation,","
R7315 T8304 T8312 arg1Of accumulation,which
R7316 T8304 T8313 arg1Of accumulation,was
R7317 T8304 T8314 arg2Of accumulation,associated
R7318 T8307 T8305 arg2Of cells,of
R7319 T8307 T8306 arg1Of cells,THP-1
R7320 T8310 T8308 arg2Of phase,in
R7321 T8310 T8309 arg1Of phase,G0/G1
R7322 T8314 T8313 arg2Of associated,was
R7323 T8314 T8315 arg1Of associated,with
R7324 T8318 T8315 arg2Of number,with
R7325 T8318 T8316 arg1Of number,a
R7326 T8318 T8317 arg1Of number,decrease
R7327 T8318 T8319 arg1Of number,of
R7328 T8318 T8321 arg1Of number,in
R7329 T8320 T8319 arg2Of cells,of
R7330 T8324 T8321 arg2Of phase,in
R7331 T8324 T8322 arg1Of phase,the
R7332 T8324 T8323 arg1Of phase,S
R7333 T8324 T8325 arg1Of phase,(
R7334 T8327 T8325 arg2Of 3A,(
R7335 T8327 T8326 arg1Of 3A,Fig.
R7336 T8328 T8325 arg3Of ),(
R7337 T8330 T8329 arg1Of percentage,The
R7338 T8330 T8331 arg1Of percentage,of
R7339 T8330 T8333 arg1Of percentage,in
R7340 T8330 T8337 arg1Of percentage,was
R7341 T8332 T8331 arg2Of cells,of
R7342 T8336 T8333 arg2Of phase,in
R7343 T8336 T8334 arg1Of phase,the
R7344 T8336 T8335 arg1Of phase,G0/G1
R7345 T8339 T8338 arg1Of %,45.2
R7346 T8339 T8340 arg1Of %,for
R7347 T8339 T8343 arg1Of %,","
R7348 T8342 T8340 arg2Of cells,for
R7349 T8342 T8341 arg1Of cells,control
R7350 T8343 T8349 arg1Of ",",(
R7351 T8343 T8355 arg1Of ",",and
R7352 T8345 T8343 arg2Of %,","
R7353 T8345 T8344 arg1Of %,62.6
R7354 T8345 T8346 arg1Of %,for
R7355 T8348 T8346 arg2Of dCGN,for
R7356 T8348 T8347 arg1Of dCGN,C10
R7357 T8350 T8349 arg2Of at,(
R7358 T8352 T8350 arg2Of mg/ml,at
R7359 T8352 T8351 arg1Of mg/ml,2
R7360 T8353 T8349 arg3Of ),(
R7361 T8355 T8337 arg2Of and,was
R7362 T8355 T8354 arg1Of and,","
R7363 T8355 T8367 arg1Of and,(
R7364 T8357 T8355 arg2Of %,and
R7365 T8357 T8356 arg1Of %,64.2
R7366 T8357 T8358 arg1Of %,for
R7367 T8361 T8358 arg2Of cells,for
R7368 T8361 T8359 arg1Of cells,C40
R7369 T8361 T8360 arg1Of cells,dCGN-treated
R7370 T8361 T8362 arg1Of cells,(
R7371 T8363 T8362 arg2Of at,(
R7372 T8365 T8363 arg2Of mg/ml,at
R7373 T8365 T8364 arg1Of mg/ml,2
R7374 T8366 T8362 arg3Of ),(
R7375 T8369 T8367 arg2Of 3B,(
R7376 T8369 T8368 arg1Of 3B,Fig.
R7377 T8370 T8367 arg3Of ),(
R7378 T8372 T8371 arg1Of effect,The
R7379 T8372 T8373 arg1Of effect,of
R7380 T8372 T8375 arg1Of effect,on
R7381 T8372 T8378 arg1Of effect,was
R7382 T8372 T8379 arg1Of effect,dose-dependent
R7383 T8374 T8373 arg2Of dCGN,of
R7384 T8377 T8375 arg2Of cycle,on
R7385 T8377 T8376 arg1Of cycle,cell
R7386 T8379 T8378 arg2Of dose-dependent,was
R7387 T8379 T8380 arg1Of dose-dependent,(
R7388 T8382 T8380 arg2Of 3B,(
R7389 T8382 T8381 arg1Of 3B,Fig.
R7390 T8383 T8380 arg3Of ),(
R7391 T8387 T8384 arg1Of dCGN,Neither
R7392 T8387 T8385 arg1Of dCGN,native
R7393 T8387 T8386 arg1Of dCGN,nor
R7394 T8387 T8388 arg1Of dCGN,had
R7395 T8390 T8388 arg2Of effect,had
R7396 T8390 T8389 arg1Of effect,an
R7397 T8390 T8391 arg1Of effect,on
R7398 T8393 T8391 arg2Of number,on
R7399 T8393 T8392 arg1Of number,the
R7400 T8393 T8394 arg1Of number,of
R7401 T8393 T8396 arg1Of number,in
R7402 T8395 T8394 arg2Of cells,of
R7403 T8399 T8396 arg2Of phase,in
R7404 T8399 T8397 arg1Of phase,the
R7405 T8399 T8398 arg1Of phase,G2/M
R7406 T8399 T8400 arg1Of phase,(
R7407 T8401 T8400 arg2Of Fig.,(
R7408 T8401 T8402 arg1Of Fig.,3
R7409 T8403 T8400 arg3Of ),(
R7410 T8405 T8404 arg1Of effect,This
R7411 T8405 T8406 arg1Of effect,is
R7412 T8405 T8408 arg1Of effect,due
R7413 T8406 T8407 arg1Of is,not
R7414 T8406 T8418 arg1Of is,(
R7415 T8406 T8423 arg1Of is,since
R7416 T8408 T8406 arg2Of due,is
R7417 T8408 T8409 arg1Of due,to
R7418 T8408 T8414 arg1Of due,at
R7419 T8410 T8409 arg2Of cytotoxicity,to
R7420 T8410 T8411 arg1Of cytotoxicity,of
R7421 T8412 T8411 arg2Of dCGN,of
R7422 T8414 T8413 arg1Of at,even
R7423 T8417 T8414 arg2Of concentration,at
R7424 T8417 T8415 arg1Of concentration,the
R7425 T8417 T8416 arg1Of concentration,highest
R7426 T8419 T8418 arg2Of i.e.,(
R7427 T8421 T8419 arg2Of mg/ml,i.e.
R7428 T8421 T8420 arg1Of mg/ml,2
R7429 T8422 T8418 arg3Of ),(
R7430 T8425 T8424 arg1Of viability,cell
R7431 T8425 T8426 arg1Of viability,was
R7432 T8425 T8428 arg2Of viability,affected
R7433 T8428 T8423 arg2Of affected,since
R7434 T8428 T8426 arg2Of affected,was
R7435 T8428 T8427 arg1Of affected,not
R7436 T8428 T8429 arg1Of affected,(
R7437 T8430 T8429 arg2Of data,(
R7438 T8430 T8432 arg2Of data,shown
R7439 T8432 T8431 arg1Of shown,not
R7440 T8433 T8429 arg3Of ),(
R14014 T16349 T16348 arg2Of CGN,Degraded
R14015 T16349 T16350 arg1Of CGN,induced
R14020 T16354 T16350 arg2Of arrest,induced
R14024 T16359 T16360 arg1Of cells,in
R14025 T16359 T16364 arg1Of cells,were
R14026 T16359 T16365 arg2Of cells,incubated
R14027 T16359 T16377 arg1Of cells,being
R14028 T16359 T16378 arg2Of cells,stained
R14029 T16363 T16360 arg2Of phase,in
R14030 T16363 T16361 arg1Of phase,exponential
R14031 T16363 T16362 arg1Of phase,growth
R14032 T16365 T16364 arg2Of incubated,were
R14033 T16365 T16366 arg1Of incubated,in
R14034 T16365 T16376 arg1Of incubated,before
R14035 T16368 T16369 arg1Of presence,or
R14036 T16369 T16366 arg2Of or,in
R14037 T16369 T16367 arg1Of or,the
R14038 T16369 T16371 arg1Of or,of
R14039 T16369 T16373 arg1Of or,for
R14040 T16370 T16369 arg2Of absence,or
R14041 T16372 T16371 arg2Of carrageenan,of
R14042 T16375 T16373 arg2Of h,for
R14043 T16375 T16374 arg1Of h,24
R14044 T16378 T16376 arg2Of stained,before
R14045 T16378 T16377 arg2Of stained,being
R14046 T16378 T16379 arg1Of stained,with
R14047 T16381 T16379 arg2Of iodide,with
R14048 T16381 T16380 arg1Of iodide,propidium
R14049 T16384 T16382 arg1Of content,Cell
R14050 T16384 T16383 arg1Of content,DNA
R14051 T16384 T16385 arg1Of content,was
R14052 T16384 T16387 arg2Of content,analyzed
R14053 T16387 T16385 arg2Of analyzed,was
R14054 T16387 T16386 arg1Of analyzed,then
R14055 T16390 T16387 arg1Of cytometry,analyzed
R14056 T16390 T16388 arg2Of cytometry,by
R14057 T16390 T16389 arg1Of cytometry,flow
R14058 T16392 T16391 arg1Of :,A
R14059 T16393 T16394 arg1Of Histograms,of
R14060 T16393 T16411 arg1Of Histograms,or
R14061 T16395 T16396 arg2Of cells,treated
R14062 T16395 T16403 arg1Of cells,","
R14063 T16396 T16397 arg1Of treated,with
R14064 T16398 T16397 arg2Of medium,with
R14065 T16398 T16399 arg1Of medium,only
R14066 T16398 T16400 arg1Of medium,(
R14067 T16401 T16400 arg2Of control,(
R14068 T16402 T16400 arg3Of ),(
R14069 T16403 T16394 arg2Of ",",of
R14070 T16406 T16403 arg2Of dCGN,","
R14071 T16406 T16404 arg1Of dCGN,10
R14072 T16406 T16405 arg1Of dCGN,kDa
R14073 T16406 T16407 arg1Of dCGN,(
R14074 T16408 T16407 arg2Of C10,(
R14075 T16409 T16407 arg3Of ),(
R14076 T16411 T16410 arg1Of or,","
R14077 T16414 T16411 arg2Of dCGN,or
R14078 T16414 T16412 arg1Of dCGN,40
R14079 T16414 T16413 arg1Of dCGN,kDa
R14080 T16414 T16415 arg1Of dCGN,(
R14081 T16416 T16415 arg2Of C40,(
R14082 T16417 T16415 arg3Of ),(
R14083 T16418 T16419 arg1Of B,:
R14084 T16420 T16421 arg1Of Percentage,of
R14085 T16420 T16423 arg1Of Percentage,in
R14086 T16420 T16431 arg2Of Percentage,treated
R14087 T16420 T16462 arg1Of Percentage,Native
R14088 T16422 T16421 arg2Of cells,of
R14089 T16425 T16423 arg2Of phase,in
R14090 T16425 T16424 arg1Of phase,each
R14091 T16425 T16426 arg1Of phase,of
R14092 T16429 T16426 arg2Of cycle,of
R14093 T16429 T16427 arg1Of cycle,the
R14094 T16429 T16428 arg1Of cycle,cell
R14095 T16431 T16432 arg1Of treated,with
R14096 T16431 T16457 arg1Of treated,or
R14097 T16433 T16434 arg1Of medium,only
R14098 T16433 T16435 arg1Of medium,(
R14099 T16433 T16438 arg1Of medium,","
R14100 T16436 T16435 arg2Of control,(
R14101 T16437 T16435 arg3Of ),(
R14102 T16438 T16432 arg2Of ",",with
R14103 T16438 T16448 arg1Of ",",","
R14104 T16438 T16449 arg1Of ",",of
R14105 T16440 T16438 arg2Of concentrations,","
R14106 T16440 T16439 arg1Of concentrations,different
R14107 T16440 T16441 arg1Of concentrations,of
R14108 T16444 T16441 arg2Of dCGN,of
R14109 T16444 T16442 arg1Of dCGN,10
R14110 T16444 T16443 arg1Of dCGN,kDa
R14111 T16444 T16445 arg1Of dCGN,(
R14112 T16446 T16445 arg2Of C10,(
R14113 T16447 T16445 arg3Of ),(
R14114 T16452 T16449 arg2Of dCGN,of
R14115 T16452 T16450 arg1Of dCGN,40
R14116 T16452 T16451 arg1Of dCGN,kDa
R14117 T16452 T16453 arg1Of dCGN,(
R14118 T16454 T16453 arg2Of C40,(
R14119 T16455 T16453 arg3Of ),(
R14120 T16457 T16430 arg1Of or,when
R14121 T16457 T16456 arg1Of or,","
R14122 T16457 T16463 arg1Of or,)
R14123 T16460 T16458 arg1Of CGN,of
R14124 T16460 T16459 arg1Of CGN,native
R14125 T16460 T16461 arg1Of CGN,(
R14126 T16462 T16457 arg2Of Native,or
R14127 T16462 T16460 arg1Of Native,CGN
R14016 T16354 T16351 arg1Of arrest,THP1
R14017 T16354 T16352 arg1Of arrest,cell
R14018 T16354 T16353 arg1Of arrest,cycle
R14019 T16354 T16355 arg1Of arrest,in
R14021 T16357 T16355 arg2Of phase,in
R14022 T16357 T16356 arg1Of phase,G1
R14023 T16359 T16358 arg1Of cells,THP-1

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T8434 0-6 NN denotes Effect
T8435 7-9 IN denotes of
T8436 10-16 JJ denotes Native
T8437 17-20 CC denotes and
T8438 21-29 JJ denotes Degraded
T8439 30-33 NNP denotes CGN
T8440 34-36 IN denotes on
T8441 37-42 NNP denotes THP-1
T8442 43-56 NNP denotes Proliferation
T8443 57-60 CC denotes and
T8444 61-65 NNP denotes Cell
T8445 66-71 NNP denotes Cycle
T8446 72-83 JJ denotes Preliminary
T8447 84-96 NNS denotes observations
T8448 97-99 IN denotes by
T8449 100-111 NN denotes enumeration
T8450 112-114 IN denotes of
T8451 115-120 CD denotes THP-1
T8452 121-126 NNS denotes cells
T8453 127-134 VBN denotes exposed
T8454 135-137 TO denotes to
T8455 138-147 JJ denotes different
T8456 148-162 NNS denotes concentrations
T8457 163-165 IN denotes of
T8458 166-172 JJ denotes native
T8459 173-176 CC denotes and
T8460 177-181 NNP denotes dCGN
T8461 182-183 -LRB- denotes (
T8462 183-185 CD denotes 10
T8463 186-189 CC denotes and
T8464 190-192 CD denotes 40
T8465 193-196 NN denotes kDa
T8466 196-197 -RRB- denotes )
T8467 198-204 IN denotes during
T8468 205-206 CD denotes 2
T8469 206-207 , denotes ,
T8470 208-209 CD denotes 5
T8471 210-213 CC denotes and
T8472 214-215 CD denotes 7
T8473 216-220 NNS denotes days
T8474 220-221 , denotes ,
T8475 222-228 VBD denotes showed
T8476 229-230 DT denotes a
T8477 231-238 NN denotes decline
T8478 239-241 IN denotes in
T8479 242-246 NN denotes cell
T8480 247-253 NN denotes number
T8481 254-255 -LRB- denotes (
T8482 255-259 NNS denotes data
T8483 260-263 RB denotes not
T8484 264-269 VBN denotes shown
T8485 269-270 -RRB- denotes )
T8486 270-271 . denotes .
T8487 272-276 DT denotes This
T8488 277-286 VBD denotes suggested
T8489 287-291 IN denotes that
T8490 292-296 NNP denotes dCGN
T8491 297-302 MD denotes might
T8492 303-308 VB denotes cause
T8493 309-311 DT denotes an
T8494 312-322 NN denotes alteration
T8495 323-325 IN denotes in
T8496 326-329 DT denotes the
T8497 330-334 NN denotes cell
T8498 335-340 NN denotes cycle
T8499 340-341 . denotes .
T8500 342-346 NNP denotes Cell
T8501 347-352 NN denotes cycle
T8502 353-361 NN denotes analysis
T8503 362-367 VBG denotes using
T8504 368-372 NN denotes flow
T8505 373-382 NN denotes cytometry
T8506 383-389 VBD denotes showed
T8507 390-392 DT denotes an
T8508 393-405 NN denotes accumulation
T8509 406-408 IN denotes of
T8510 409-414 CD denotes THP-1
T8511 415-420 NNS denotes cells
T8512 421-423 IN denotes in
T8513 424-429 NNP denotes G0/G1
T8514 430-435 NN denotes phase
T8515 435-436 , denotes ,
T8516 437-442 WDT denotes which
T8517 443-446 VBD denotes was
T8518 447-457 VBN denotes associated
T8519 458-462 IN denotes with
T8520 463-464 DT denotes a
T8521 465-473 NN denotes decrease
T8522 474-480 NN denotes number
T8523 481-483 IN denotes of
T8524 484-489 NNS denotes cells
T8525 490-492 IN denotes in
T8526 493-496 DT denotes the
T8527 497-498 NNP denotes S
T8528 499-504 NN denotes phase
T8529 505-506 -LRB- denotes (
T8530 506-510 NNP denotes Fig.
T8531 511-513 NNP denotes 3A
T8532 513-514 -RRB- denotes )
T8533 514-515 . denotes .
T8534 516-519 DT denotes The
T8535 520-530 NN denotes percentage
T8536 531-533 IN denotes of
T8537 534-539 NNS denotes cells
T8538 540-542 IN denotes in
T8539 543-546 DT denotes the
T8540 547-552 NNP denotes G0/G1
T8541 553-558 NN denotes phase
T8542 559-562 VBD denotes was
T8543 563-567 CD denotes 45.2
T8544 567-568 NN denotes %
T8545 569-572 IN denotes for
T8546 573-580 NN denotes control
T8547 581-586 NNS denotes cells
T8548 586-587 , denotes ,
T8549 588-592 CD denotes 62.6
T8550 592-593 NN denotes %
T8551 594-597 IN denotes for
T8552 598-601 NNP denotes C10
T8553 602-606 NNP denotes dCGN
T8554 607-608 -LRB- denotes (
T8555 608-610 IN denotes at
T8556 611-612 CD denotes 2
T8557 613-618 NN denotes mg/ml
T8558 618-619 -RRB- denotes )
T8559 619-620 , denotes ,
T8560 621-624 CC denotes and
T8561 625-629 CD denotes 64.2
T8562 629-630 NN denotes %
T8563 631-634 IN denotes for
T8564 635-638 NNP denotes C40
T8565 639-651 NNP denotes dCGN-treated
T8566 652-657 NNS denotes cells
T8567 658-659 -LRB- denotes (
T8568 659-661 IN denotes at
T8569 662-663 CD denotes 2
T8570 664-669 NN denotes mg/ml
T8571 669-670 -RRB- denotes )
T8572 671-672 -LRB- denotes (
T8573 672-676 NNP denotes Fig.
T8574 677-679 NNP denotes 3B
T8575 679-680 -RRB- denotes )
T8576 680-681 . denotes .
T8577 682-685 DT denotes The
T8578 686-692 NN denotes effect
T8579 693-695 IN denotes of
T8580 696-700 NNP denotes dCGN
T8581 701-703 IN denotes on
T8582 704-708 NN denotes cell
T8583 709-714 NN denotes cycle
T8584 715-718 VBD denotes was
T8585 719-733 JJ denotes dose-dependent
T8586 734-735 -LRB- denotes (
T8587 735-739 NNP denotes Fig.
T8588 740-742 NNP denotes 3B
T8589 742-743 -RRB- denotes )
T8590 743-744 . denotes .
T8591 745-752 DT denotes Neither
T8592 753-759 JJ denotes native
T8593 760-763 CC denotes nor
T8594 764-768 JJ denotes dCGN
T8595 769-772 VBD denotes had
T8596 773-775 DT denotes an
T8597 776-782 NN denotes effect
T8598 783-785 IN denotes on
T8599 786-789 DT denotes the
T8600 790-796 NN denotes number
T8601 797-799 IN denotes of
T8602 800-805 NNS denotes cells
T8603 806-808 IN denotes in
T8604 809-812 DT denotes the
T8605 813-817 NNP denotes G2/M
T8606 818-823 NN denotes phase
T8607 824-825 -LRB- denotes (
T8608 825-829 FW denotes Fig.
T8609 830-831 LS denotes 3
T8610 831-832 -RRB- denotes )
T8611 832-833 . denotes .
T8612 834-838 DT denotes This
T8613 839-845 NN denotes effect
T8614 846-848 VBZ denotes is
T8615 849-852 RB denotes not
T8616 853-856 JJ denotes due
T8617 857-859 TO denotes to
T8618 860-872 NN denotes cytotoxicity
T8619 873-875 IN denotes of
T8620 876-880 NNP denotes dCGN
T8621 881-885 RB denotes even
T8622 886-888 IN denotes at
T8623 889-892 DT denotes the
T8624 893-900 JJS denotes highest
T8625 901-914 NN denotes concentration
T8626 915-916 -LRB- denotes (
T8627 916-920 FW denotes i.e.
T8628 921-922 CD denotes 2
T8629 923-928 NN denotes mg/ml
T8630 928-929 -RRB- denotes )
T8631 930-935 IN denotes since
T8632 936-940 NN denotes cell
T8633 941-950 NN denotes viability
T8634 951-954 VBD denotes was
T8635 955-958 RB denotes not
T8636 959-967 JJ denotes affected
T8637 968-969 -LRB- denotes (
T8638 969-973 NNS denotes data
T8639 974-977 RB denotes not
T8640 978-983 VBN denotes shown
T8641 983-984 -RRB- denotes )
T8642 984-985 . denotes .
T16464 1030-1038 JJ denotes Degraded
T16465 1039-1042 NNP denotes CGN
T16466 1043-1050 VBD denotes induced
T16467 1051-1055 CD denotes THP1
T16468 1056-1060 NN denotes cell
T16469 1061-1066 NN denotes cycle
T16470 1067-1073 NN denotes arrest
T16471 1074-1076 IN denotes in
T16472 1077-1079 CD denotes G1
T16473 1080-1085 NN denotes phase
T16474 1085-1086 . denotes .
T16475 1087-1092 CD denotes THP-1
T16476 1093-1098 NNS denotes cells
T16477 1099-1101 IN denotes in
T16478 1102-1113 JJ denotes exponential
T16479 1114-1120 NN denotes growth
T16480 1121-1126 NN denotes phase
T16481 1127-1131 VBD denotes were
T16482 1132-1141 VBN denotes incubated
T16483 1142-1144 IN denotes in
T16484 1145-1148 DT denotes the
T16485 1149-1157 NN denotes presence
T16486 1158-1160 CC denotes or
T16487 1161-1168 NN denotes absence
T16488 1169-1171 IN denotes of
T16489 1172-1183 NN denotes carrageenan
T16490 1184-1187 IN denotes for
T16491 1188-1190 CD denotes 24
T16492 1191-1192 NN denotes h
T16493 1193-1199 IN denotes before
T16494 1200-1205 VBG denotes being
T16495 1206-1213 VBN denotes stained
T16496 1214-1218 IN denotes with
T16497 1219-1228 NN denotes propidium
T16498 1229-1235 NN denotes iodide
T16499 1235-1236 . denotes .
T16500 1237-1241 NNP denotes Cell
T16501 1242-1245 NNP denotes DNA
T16502 1246-1253 NN denotes content
T16503 1254-1257 VBD denotes was
T16504 1258-1262 RB denotes then
T16505 1263-1271 VBN denotes analyzed
T16506 1272-1274 IN denotes by
T16507 1275-1279 NN denotes flow
T16508 1280-1289 NN denotes cytometry
T16509 1289-1290 . denotes .
T16510 1291-1292 DT denotes A
T16511 1292-1293 : denotes :
T16512 1294-1304 NNS denotes Histograms
T16513 1305-1307 IN denotes of
T16514 1308-1313 NNS denotes cells
T16515 1314-1321 VBN denotes treated
T16516 1322-1326 IN denotes with
T16517 1327-1333 NN denotes medium
T16518 1334-1338 RB denotes only
T16519 1339-1340 -LRB- denotes (
T16520 1340-1347 NN denotes control
T16521 1347-1348 -RRB- denotes )
T16522 1348-1349 , denotes ,
T16523 1350-1352 CD denotes 10
T16524 1353-1356 NNP denotes kDa
T16525 1357-1361 NNP denotes dCGN
T16526 1362-1363 -LRB- denotes (
T16527 1363-1366 NNP denotes C10
T16528 1366-1367 -RRB- denotes )
T16529 1367-1368 , denotes ,
T16530 1369-1371 CC denotes or
T16531 1372-1374 CD denotes 40
T16532 1375-1378 NNP denotes kDa
T16533 1379-1383 NNP denotes dCGN
T16534 1384-1385 -LRB- denotes (
T16535 1385-1388 NNP denotes C40
T16536 1388-1389 -RRB- denotes )
T16537 1389-1390 . denotes .
T16538 1391-1392 NNP denotes B
T16539 1392-1393 : denotes :
T16540 1394-1404 NN denotes Percentage
T16541 1405-1407 IN denotes of
T16542 1408-1413 NNS denotes cells
T16543 1414-1416 IN denotes in
T16544 1417-1421 DT denotes each
T16545 1422-1427 NN denotes phase
T16546 1428-1430 IN denotes of
T16547 1431-1434 DT denotes the
T16548 1435-1439 NN denotes cell
T16549 1440-1445 NN denotes cycle
T16550 1446-1450 WRB denotes when
T16551 1451-1458 VBN denotes treated
T16552 1459-1463 IN denotes with
T16553 1464-1470 NN denotes medium
T16554 1471-1475 RB denotes only
T16555 1476-1477 -LRB- denotes (
T16556 1477-1484 NN denotes control
T16557 1484-1485 -RRB- denotes )
T16558 1485-1486 , denotes ,
T16559 1487-1496 JJ denotes different
T16560 1497-1511 NNS denotes concentrations
T16561 1512-1514 IN denotes of
T16562 1515-1517 CD denotes 10
T16563 1518-1521 NNP denotes kDa
T16564 1522-1526 NNP denotes dCGN
T16565 1527-1528 -LRB- denotes (
T16566 1528-1531 NNP denotes C10
T16567 1531-1532 -RRB- denotes )
T16568 1532-1533 , denotes ,
T16569 1534-1536 IN denotes of
T16570 1537-1539 CD denotes 40
T16571 1540-1543 NNP denotes kDa
T16572 1544-1548 NNP denotes dCGN
T16573 1549-1550 -LRB- denotes (
T16574 1550-1553 NNP denotes C40
T16575 1553-1554 -RRB- denotes )
T16576 1554-1555 , denotes ,
T16577 1556-1558 CC denotes or
T16578 1559-1561 IN denotes of
T16579 1562-1568 JJ denotes native
T16580 1569-1572 NNP denotes CGN
T16581 1573-1574 -LRB- denotes (
T16582 1574-1580 NNP denotes Native
T16583 1580-1581 -RRB- denotes )
T16584 1581-1582 . denotes .
R7441 T8434 T8447 nmod Effect,observations
R7442 T8435 T8434 prep of,Effect
R7443 T8436 T8439 amod Native,CGN
R7444 T8437 T8436 cc and,Native
R7445 T8438 T8436 conj Degraded,Native
R7446 T8439 T8435 pobj CGN,of
R7447 T8440 T8439 prep on,CGN
R7448 T8441 T8442 compound THP-1,Proliferation
R7449 T8442 T8440 pobj Proliferation,on
R7450 T8443 T8442 cc and,Proliferation
R7451 T8444 T8445 compound Cell,Cycle
R7452 T8445 T8442 conj Cycle,Proliferation
R7453 T8446 T8447 amod Preliminary,observations
R7454 T8447 T8475 nsubj observations,showed
R7455 T8448 T8447 prep by,observations
R7456 T8449 T8448 pobj enumeration,by
R7457 T8450 T8449 prep of,enumeration
R7458 T8451 T8452 nummod THP-1,cells
R7459 T8452 T8450 pobj cells,of
R7460 T8453 T8452 acl exposed,cells
R7461 T8454 T8453 prep to,exposed
R7462 T8455 T8456 amod different,concentrations
R7463 T8456 T8454 pobj concentrations,to
R7464 T8457 T8456 prep of,concentrations
R7465 T8458 T8457 pobj native,of
R7466 T8459 T8458 cc and,native
R7467 T8460 T8458 conj dCGN,native
R7468 T8461 T8460 punct (,dCGN
R7469 T8462 T8465 nummod 10,kDa
R7470 T8463 T8462 cc and,10
R7471 T8464 T8462 conj 40,10
R7472 T8465 T8460 appos kDa,dCGN
R7473 T8466 T8460 punct ),dCGN
R7474 T8467 T8453 prep during,exposed
R7475 T8468 T8473 nummod 2,days
R7476 T8469 T8468 punct ",",2
R7477 T8470 T8468 conj 5,2
R7478 T8471 T8470 cc and,5
R7479 T8472 T8470 conj 7,5
R7480 T8473 T8467 pobj days,during
R7481 T8474 T8475 punct ",",showed
R7482 T8475 T8475 ROOT showed,showed
R7483 T8476 T8477 det a,decline
R7484 T8477 T8475 dobj decline,showed
R7485 T8478 T8477 prep in,decline
R7486 T8479 T8480 compound cell,number
R7487 T8480 T8478 pobj number,in
R7488 T8481 T8480 punct (,number
R7489 T8482 T8480 appos data,number
R7490 T8483 T8484 neg not,shown
R7491 T8484 T8482 acl shown,data
R7492 T8485 T8482 punct ),data
R7493 T8486 T8475 punct .,showed
R7494 T8487 T8488 nsubj This,suggested
R7495 T8488 T8488 ROOT suggested,suggested
R7496 T8489 T8492 mark that,cause
R7497 T8490 T8492 nsubj dCGN,cause
R7498 T8491 T8492 aux might,cause
R7499 T8492 T8488 ccomp cause,suggested
R7500 T8493 T8494 det an,alteration
R7501 T8494 T8492 dobj alteration,cause
R7502 T8495 T8494 prep in,alteration
R7503 T8496 T8498 det the,cycle
R7504 T8497 T8498 compound cell,cycle
R7505 T8498 T8495 pobj cycle,in
R7506 T8499 T8488 punct .,suggested
R7507 T8500 T8501 compound Cell,cycle
R7508 T8501 T8502 compound cycle,analysis
R7509 T8502 T8506 nsubj analysis,showed
R7510 T8503 T8502 acl using,analysis
R7511 T8504 T8505 compound flow,cytometry
R7512 T8505 T8503 dobj cytometry,using
R7513 T8506 T8506 ROOT showed,showed
R7514 T8507 T8508 det an,accumulation
R7515 T8508 T8506 dobj accumulation,showed
R7516 T8509 T8508 prep of,accumulation
R7517 T8510 T8511 nummod THP-1,cells
R7518 T8511 T8509 pobj cells,of
R7519 T8512 T8508 prep in,accumulation
R7520 T8513 T8514 compound G0/G1,phase
R7521 T8514 T8512 pobj phase,in
R7522 T8515 T8514 punct ",",phase
R7523 T8516 T8518 nsubjpass which,associated
R7524 T8517 T8518 auxpass was,associated
R7525 T8518 T8514 relcl associated,phase
R7526 T8519 T8518 prep with,associated
R7527 T8520 T8522 det a,number
R7528 T8521 T8522 compound decrease,number
R7529 T8522 T8519 pobj number,with
R7530 T8523 T8522 prep of,number
R7531 T8524 T8523 pobj cells,of
R7532 T8525 T8522 prep in,number
R7533 T8526 T8528 det the,phase
R7534 T8527 T8528 compound S,phase
R7535 T8528 T8525 pobj phase,in
R7536 T8529 T8522 punct (,number
R7537 T8530 T8531 compound Fig.,3A
R7538 T8531 T8522 appos 3A,number
R7539 T8532 T8522 punct ),number
R7540 T8533 T8506 punct .,showed
R7541 T8534 T8535 det The,percentage
R7542 T8535 T8542 nsubj percentage,was
R7543 T8536 T8535 prep of,percentage
R7544 T8537 T8536 pobj cells,of
R7545 T8538 T8535 prep in,percentage
R7546 T8539 T8541 det the,phase
R7547 T8540 T8541 compound G0/G1,phase
R7548 T8541 T8538 pobj phase,in
R7549 T8542 T8542 ROOT was,was
R7550 T8543 T8544 nummod 45.2,%
R7551 T8544 T8542 attr %,was
R7552 T8545 T8544 prep for,%
R7553 T8546 T8547 compound control,cells
R7554 T8547 T8545 pobj cells,for
R7555 T8548 T8544 punct ",",%
R7556 T8549 T8550 nummod 62.6,%
R7557 T8550 T8544 appos %,%
R7558 T8551 T8550 prep for,%
R7559 T8552 T8553 compound C10,dCGN
R7560 T8553 T8551 pobj dCGN,for
R7561 T8554 T8555 punct (,at
R7562 T8555 T8550 prep at,%
R7563 T8556 T8557 nummod 2,mg/ml
R7564 T8557 T8555 pobj mg/ml,at
R7565 T8558 T8544 punct ),%
R7566 T8559 T8542 punct ",",was
R7567 T8560 T8542 cc and,was
R7568 T8561 T8562 nummod 64.2,%
R7569 T8562 T8542 conj %,was
R7570 T8563 T8562 prep for,%
R7571 T8564 T8565 compound C40,dCGN-treated
R7572 T8565 T8566 compound dCGN-treated,cells
R7573 T8566 T8563 pobj cells,for
R7574 T8567 T8568 punct (,at
R7575 T8568 T8562 parataxis at,%
R7576 T8569 T8570 nummod 2,mg/ml
R7577 T8570 T8568 pobj mg/ml,at
R7578 T8571 T8568 punct ),at
R7579 T8572 T8574 punct (,3B
R7580 T8573 T8574 compound Fig.,3B
R7581 T8574 T8562 appos 3B,%
R7582 T8575 T8574 punct ),3B
R7583 T8576 T8542 punct .,was
R7584 T8577 T8578 det The,effect
R7585 T8578 T8584 nsubj effect,was
R7586 T8579 T8578 prep of,effect
R7587 T8580 T8579 pobj dCGN,of
R7588 T8581 T8578 prep on,effect
R7589 T8582 T8583 compound cell,cycle
R7590 T8583 T8581 pobj cycle,on
R7591 T8584 T8584 ROOT was,was
R7592 T8585 T8584 acomp dose-dependent,was
R7593 T8586 T8588 punct (,3B
R7594 T8587 T8588 compound Fig.,3B
R7595 T8588 T8585 appos 3B,dose-dependent
R7596 T8589 T8588 punct ),3B
R7597 T8590 T8584 punct .,was
R7598 T8591 T8595 nsubj Neither,had
R7599 T8592 T8595 nsubj native,had
R7600 T8593 T8592 cc nor,native
R7601 T8594 T8592 conj dCGN,native
R7602 T8595 T8595 ROOT had,had
R7603 T8596 T8597 det an,effect
R7604 T8597 T8595 dobj effect,had
R7605 T8598 T8597 prep on,effect
R7606 T8599 T8600 det the,number
R7607 T8600 T8598 pobj number,on
R7608 T8601 T8600 prep of,number
R7609 T8602 T8601 pobj cells,of
R7610 T8603 T8600 prep in,number
R7611 T8604 T8606 det the,phase
R7612 T8605 T8606 compound G2/M,phase
R7613 T8606 T8603 pobj phase,in
R7614 T8607 T8600 punct (,number
R7615 T8608 T8600 appos Fig.,number
R7616 T8609 T8608 nummod 3,Fig.
R7617 T8610 T8600 punct ),number
R7618 T8611 T8595 punct .,had
R7619 T8612 T8613 det This,effect
R7620 T8613 T8614 nsubj effect,is
R7621 T8614 T8614 ROOT is,is
R7622 T8615 T8614 neg not,is
R7623 T8616 T8614 acomp due,is
R7624 T8617 T8616 prep to,due
R7625 T8618 T8617 pobj cytotoxicity,to
R7626 T8619 T8618 prep of,cytotoxicity
R7627 T8620 T8619 pobj dCGN,of
R7628 T8621 T8622 advmod even,at
R7629 T8622 T8614 prep at,is
R7630 T8623 T8625 det the,concentration
R7631 T8624 T8625 amod highest,concentration
R7632 T8625 T8622 pobj concentration,at
R7633 T8626 T8629 punct (,mg/ml
R7634 T8627 T8628 advmod i.e.,2
R7635 T8628 T8629 nummod 2,mg/ml
R7636 T8629 T8625 appos mg/ml,concentration
R7637 T8630 T8625 punct ),concentration
R7638 T8631 T8634 mark since,was
R7639 T8632 T8633 compound cell,viability
R7640 T8633 T8634 nsubj viability,was
R7641 T8634 T8614 advcl was,is
R7642 T8635 T8636 neg not,affected
R7643 T8636 T8634 acomp affected,was
R7644 T8637 T8640 punct (,shown
R7645 T8638 T8640 nsubjpass data,shown
R7646 T8639 T8640 neg not,shown
R7647 T8640 T8634 parataxis shown,was
R7648 T8641 T8640 punct ),shown
R7649 T8642 T8614 punct .,is
R14128 T16464 T16465 amod Degraded,CGN
R14129 T16465 T16466 nsubj CGN,induced
R14130 T16466 T16466 ROOT induced,induced
R14131 T16467 T16470 nummod THP1,arrest
R14132 T16468 T16469 compound cell,cycle
R14133 T16469 T16470 compound cycle,arrest
R14134 T16470 T16466 dobj arrest,induced
R14135 T16471 T16466 prep in,induced
R14136 T16472 T16473 nummod G1,phase
R14137 T16473 T16471 pobj phase,in
R14138 T16474 T16466 punct .,induced
R14139 T16475 T16476 nummod THP-1,cells
R14140 T16476 T16482 nsubjpass cells,incubated
R14141 T16477 T16476 prep in,cells
R14142 T16478 T16480 amod exponential,phase
R14143 T16479 T16480 compound growth,phase
R14144 T16480 T16477 pobj phase,in
R14145 T16481 T16482 auxpass were,incubated
R14146 T16482 T16482 ROOT incubated,incubated
R14147 T16483 T16482 prep in,incubated
R14148 T16484 T16485 det the,presence
R14149 T16485 T16483 pobj presence,in
R14150 T16486 T16485 cc or,presence
R14151 T16487 T16485 conj absence,presence
R14152 T16488 T16487 prep of,absence
R14153 T16489 T16488 pobj carrageenan,of
R14154 T16490 T16482 prep for,incubated
R14155 T16491 T16492 nummod 24,h
R14156 T16492 T16490 pobj h,for
R14157 T16493 T16482 prep before,incubated
R14158 T16494 T16495 auxpass being,stained
R14159 T16495 T16493 pcomp stained,before
R14160 T16496 T16495 prep with,stained
R14161 T16497 T16498 compound propidium,iodide
R14162 T16498 T16496 pobj iodide,with
R14163 T16499 T16482 punct .,incubated
R14164 T16500 T16501 compound Cell,DNA
R14165 T16501 T16502 compound DNA,content
R14166 T16502 T16505 nsubjpass content,analyzed
R14167 T16503 T16505 auxpass was,analyzed
R14168 T16504 T16505 advmod then,analyzed
R14169 T16505 T16505 ROOT analyzed,analyzed
R14170 T16506 T16505 agent by,analyzed
R14171 T16507 T16508 compound flow,cytometry
R14172 T16508 T16506 pobj cytometry,by
R14173 T16509 T16505 punct .,analyzed
R14174 T16510 T16512 compound A,Histograms
R14175 T16511 T16510 punct :,A
R14176 T16512 T16512 ROOT Histograms,Histograms
R14177 T16513 T16512 prep of,Histograms
R14178 T16514 T16513 pobj cells,of
R14179 T16515 T16514 acl treated,cells
R14180 T16516 T16515 prep with,treated
R14181 T16517 T16516 pobj medium,with
R14182 T16518 T16520 advmod only,control
R14183 T16519 T16520 punct (,control
R14184 T16520 T16517 appos control,medium
R14185 T16521 T16520 punct ),control
R14186 T16522 T16520 punct ",",control
R14187 T16523 T16525 nummod 10,dCGN
R14188 T16524 T16525 compound kDa,dCGN
R14189 T16525 T16520 appos dCGN,control
R14190 T16526 T16527 punct (,C10
R14191 T16527 T16525 appos C10,dCGN
R14192 T16528 T16527 punct ),C10
R14193 T16529 T16525 punct ",",dCGN
R14194 T16530 T16525 cc or,dCGN
R14195 T16531 T16533 nummod 40,dCGN
R14196 T16532 T16533 compound kDa,dCGN
R14197 T16533 T16525 conj dCGN,dCGN
R14198 T16534 T16533 punct (,dCGN
R14199 T16535 T16533 appos C40,dCGN
R14200 T16536 T16533 punct ),dCGN
R14201 T16537 T16512 punct .,Histograms
R14202 T16538 T16538 ROOT B,B
R14203 T16539 T16538 punct :,B
R14204 T16540 T16538 appos Percentage,B
R14205 T16541 T16540 prep of,Percentage
R14206 T16542 T16541 pobj cells,of
R14207 T16543 T16540 prep in,Percentage
R14208 T16544 T16545 det each,phase
R14209 T16545 T16543 pobj phase,in
R14210 T16546 T16545 prep of,phase
R14211 T16547 T16549 det the,cycle
R14212 T16548 T16549 compound cell,cycle
R14213 T16549 T16546 pobj cycle,of
R14214 T16550 T16551 advmod when,treated
R14215 T16551 T16540 advcl treated,Percentage
R14216 T16552 T16551 prep with,treated
R14217 T16553 T16552 pobj medium,with
R14218 T16554 T16556 advmod only,control
R14219 T16555 T16556 punct (,control
R14220 T16556 T16553 appos control,medium
R14221 T16557 T16556 punct ),control
R14222 T16558 T16556 punct ",",control
R14223 T16559 T16560 amod different,concentrations
R14224 T16560 T16556 conj concentrations,control
R14225 T16561 T16560 prep of,concentrations
R14226 T16562 T16564 nummod 10,dCGN
R14227 T16563 T16564 compound kDa,dCGN
R14228 T16564 T16561 pobj dCGN,of
R14229 T16565 T16564 punct (,dCGN
R14230 T16566 T16564 appos C10,dCGN
R14231 T16567 T16564 punct ),dCGN
R14232 T16568 T16564 punct ",",dCGN
R14233 T16569 T16564 prep of,dCGN
R14234 T16570 T16572 nummod 40,dCGN
R14235 T16571 T16572 compound kDa,dCGN
R14236 T16572 T16569 pobj dCGN,of
R14237 T16573 T16572 punct (,dCGN
R14238 T16574 T16572 appos C40,dCGN
R14239 T16575 T16572 punct ),dCGN
R14240 T16576 T16564 punct ",",dCGN
R14241 T16577 T16561 cc or,of
R14242 T16578 T16561 conj of,of
R14243 T16579 T16580 amod native,CGN
R14244 T16580 T16578 pobj CGN,of
R14245 T16581 T16580 punct (,CGN
R14246 T16582 T16580 appos Native,CGN
R14247 T16583 T16580 punct ),CGN
R14248 T16584 T16538 punct .,B

sentences

Id Subject Object Predicate Lexical cue
T8224 0-71 Sentence denotes Effect of Native and Degraded CGN on THP-1 Proliferation and Cell Cycle
T8225 72-271 Sentence denotes Preliminary observations by enumeration of THP-1 cells exposed to different concentrations of native and dCGN (10 and 40 kDa) during 2, 5 and 7 days, showed a decline in cell number (data not shown).
T8226 272-341 Sentence denotes This suggested that dCGN might cause an alteration in the cell cycle.
T8227 342-515 Sentence denotes Cell cycle analysis using flow cytometry showed an accumulation of THP-1 cells in G0/G1 phase, which was associated with a decrease number of cells in the S phase (Fig. 3A).
T8228 516-681 Sentence denotes The percentage of cells in the G0/G1 phase was 45.2% for control cells, 62.6% for C10 dCGN (at 2 mg/ml), and 64.2% for C40 dCGN-treated cells (at 2 mg/ml) (Fig. 3B).
T8229 682-744 Sentence denotes The effect of dCGN on cell cycle was dose-dependent (Fig. 3B).
T8230 745-833 Sentence denotes Neither native nor dCGN had an effect on the number of cells in the G2/M phase (Fig. 3).
T8231 834-985 Sentence denotes This effect is not due to cytotoxicity of dCGN even at the highest concentration (i.e. 2 mg/ml) since cell viability was not affected (data not shown).
T16341 1030-1086 Sentence denotes Degraded CGN induced THP1 cell cycle arrest in G1 phase.
T16342 1087-1236 Sentence denotes THP-1 cells in exponential growth phase were incubated in the presence or absence of carrageenan for 24 h before being stained with propidium iodide.
T16343 1237-1290 Sentence denotes Cell DNA content was then analyzed by flow cytometry.
T16344 1291-1293 Sentence denotes A:
T16345 1294-1390 Sentence denotes Histograms of cells treated with medium only (control), 10 kDa dCGN (C10), or 40 kDa dCGN (C40).
T16346 1391-1393 Sentence denotes B:
T16347 1394-1582 Sentence denotes Percentage of cells in each phase of the cell cycle when treated with medium only (control), different concentrations of 10 kDa dCGN (C10), of 40 kDa dCGN (C40), or of native CGN (Native).
T176 0-71 Sentence denotes Effect of Native and Degraded CGN on THP-1 Proliferation and Cell Cycle
T177 72-271 Sentence denotes Preliminary observations by enumeration of THP-1 cells exposed to different concentrations of native and dCGN (10 and 40 kDa) during 2, 5 and 7 days, showed a decline in cell number (data not shown).
T178 272-341 Sentence denotes This suggested that dCGN might cause an alteration in the cell cycle.
T179 342-515 Sentence denotes Cell cycle analysis using flow cytometry showed an accumulation of THP-1 cells in G0/G1 phase, which was associated with a decrease number of cells in the S phase (Fig. 3A).
T180 516-681 Sentence denotes The percentage of cells in the G0/G1 phase was 45.2% for control cells, 62.6% for C10 dCGN (at 2 mg/ml), and 64.2% for C40 dCGN-treated cells (at 2 mg/ml) (Fig. 3B).
T181 682-744 Sentence denotes The effect of dCGN on cell cycle was dose-dependent (Fig. 3B).
T182 745-833 Sentence denotes Neither native nor dCGN had an effect on the number of cells in the G2/M phase (Fig. 3).
T183 834-985 Sentence denotes This effect is not due to cytotoxicity of dCGN even at the highest concentration (i.e. 2 mg/ml) since cell viability was not affected (data not shown).
T184 986-1086 Sentence denotes 10.1371/journal.pone.0008666.g003 Figure 3 Degraded CGN induced THP1 cell cycle arrest in G1 phase.
T185 1087-1236 Sentence denotes THP-1 cells in exponential growth phase were incubated in the presence or absence of carrageenan for 24 h before being stained with propidium iodide.
T186 1237-1290 Sentence denotes Cell DNA content was then analyzed by flow cytometry.
T187 1291-1293 Sentence denotes A:
T188 1294-1390 Sentence denotes Histograms of cells treated with medium only (control), 10 kDa dCGN (C10), or 40 kDa dCGN (C40).
T189 1391-1393 Sentence denotes B:
T190 1394-1582 Sentence denotes Percentage of cells in each phase of the cell cycle when treated with medium only (control), different concentrations of 10 kDa dCGN (C10), of 40 kDa dCGN (C40), or of native CGN (Native).

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T8668 598-606 Protein denotes C10 dCGN
T16606 1051-1055 Protein denotes THP1
T16607 1043-1050 Positive_regulation denotes induced
R14249 T16606 T16607 themeOf THP1,induced